Employees Provident Fund Board’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$68.8M Sell
535,502
-1,359,663
-72% -$159M 0.39% 42
2026
Q1
$228M Sell
1,895,165
-519,869
-22% -$60M 1.72% 22
2025
Q4
$254M Buy
2,415,034
+61,000
+3% +$5.73M 1.87% 15
2025
Q3
$198M Buy
2,354,034
+665,000
+39% +$54.8M 1.59% 24
2025
Q2
$134M Buy
1,689,034
+179,000
+12% +$14.2M 1.16% 30
2025
Q1
$136M Buy
1,510,034
+458,969
+44% +$42.9M 1.54% 24
2024
Q4
$105M Buy
1,051,065
+25,000
+2% +$2.58M 1.3% 35
2024
Q3
$117M Buy
1,026,065
+28,056
+3% +$3.33M 1.6% 19
2024
Q2
$124M Sell
998,009
-172,178
-15% -$22.2M 1.98% 14
2024
Q1
$154M Sell
1,170,187
-14,326
-1% -$1.77M 2.71% 7
2023
Q4
$129M Buy
1,184,513
+216,111
+22% +$22.4M 2.52% 12
2023
Q3
$99.7M Buy
968,402
+270,503
+39% +$29.2M 2.26% 12
2023
Q2
$80.5M Buy
697,899
+234,450
+51% +$26.6M 1.91% 20
2023
Q1
$49.3M Buy
463,449
+88,449
+24% +$9.55M 1.27% 34
2022
Q4
$41.6M Sell
375,000
-739,273
-66% -$75.6M 1.2% 31
2022
Q3
$96M Sell
1,114,273
-1,000,339
-47% -$89.3M 2.8% 11
2022
Q2
$193M Sell
2,114,612
-566,789
-21% -$50.2M 4.36% 4
2022
Q1
$220M Buy
2,681,401
+245,053
+10% +$19.3M 3.78% 5
2021
Q4
$187M Sell
2,436,348
-186,980
-7% -$14.9M 3.08% 10
2021
Q3
$197M Buy
2,623,328
+112,884
+4% +$8.59M 3.25% 9
2021
Q2
$195M Buy
2,510,444
+69,164
+3% +$5.14M 3.22% 9
2021
Q1
$180M Buy
2,441,280
+573,468
+31% +$42.3M 3.07% 8
2020
Q4
$146M Buy
1,867,812
+620,337
+50% +$47.4M 2.48% 13
2020
Q3
$98.7M Buy
1,247,475
+1,244,017
+35,975% +$97.4M 2.07% 19
2020
Q2
$255K Sell
3,458
-1,885,639
-100% -$142M 0.01% 63
2020
Q1
$139M Buy
1,889,097
+869,849
+85% +$68.4M 3.77% 6
2019
Q4
$88.5M Buy
1,019,248
+355,654
+54% +$29.2M 1.87% 21
2019
Q3
$53.3M Sell
663,594
-58,823
-8% -$4.71M 1.43% 27
2019
Q2
$57.8M Sell
722,417
-287,801
-28% -$22M 1.52% 24
2019
Q1
$80.2M Sell
1,010,218
-229,518
-19% -$17.2M 2.22% 17
2018
Q4
$90.4M Sell
1,239,736
-229,581
-16% -$16.2M 2.53% 11
2018
Q3
$99.5M Sell
1,469,317
-1,187,962
-45% -$75.7M 2.75% 10
2018
Q2
$154M Buy
2,657,279
+298,009
+13% +$16.8M 4.18% 5
2018
Q1
$123M Sell
2,359,270
-65,335
-3% -$3.53M 3.66% 5
2017
Q4
$130M Buy
2,424,605
+741,034
+44% +$41.1M 3.48% 8
2017
Q3
$103M Buy
1,683,571
+274,656
+19% +$16.7M 2.92% 9
2017
Q2
$86.2M Sell
1,408,915
-359,577
-20% -$21.9M 2.47% 11
2017
Q1
$107M Sell
1,768,492
-171,365
-9% -$10.4M 3.13% 10
2016
Q4
$109M Buy
1,939,857
+288,122
+17% +$16.9M 3.73% 10
2016
Q3
$98.4M Sell
1,651,735
-117,784
-7% -$6.89M 3.5% 10
2016
Q2
$97.3M Buy
1,769,519
+105,811
+6% +$5.63M 4.14% 9
2016
Q1
$84M Sell
1,663,708
-55,479
-3% -$2.72M 3.59% 11
2015
Q4
$86.6M Buy
1,719,187
+65,685
+4% +$3.31M 2.96% 13
2015
Q3
$77.9M Buy
1,653,502
+1,572
+0.1% +$83.5K 2.96% 13
2015
Q2
$89.7M Sell
1,651,930
-47,186
-3% -$2.65M 3.14% 12
2015
Q1
$93.2M Sell
1,699,116
-25,328
-1% -$1.43M 3.17% 14
2014
Q4
$93.4M Buy
1,724,444
+160,110
+10% +$8.92M 2.86% 16
2014
Q3
$88.5M Sell
1,564,334
-34,585
-2% -$1.94M 2.79% 14
2014
Q2
$88.3M Sell
1,598,919
-265,127
-14% -$14.5M 2.78% 15
2014
Q1
$94.2M Sell
1,864,046
-33,536
-2% -$1.74M 3.04% 13
2013
Q4
$90.6M Buy
1,897,582
+201,708
+12% +$9.22M 2.74% 14
2013
Q3
$77M Sell
1,695,874
-49,171
-3% -$2.25M 2.78% 16
2013
Q2
$77.3M Buy
+1,745,045
New +$77.9M 3.1% 14

Other funds holding MRK

Employees Provident Fund Board's MRK Position: Q2 2026 in Review

Employees Provident Fund Board reduced its Merck (MRK) stake by 72% in Q2 2026, selling an estimated $159M and leaving 535,502 shares worth $68.8M. The position accounts for 0.39% of the portfolio, ranked #42.

Employees Provident Fund Board first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $254M in Q4 2025. 3,813 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Employees Provident Fund Board held 535,502 shares of Merck worth $68.8M as of Q2 2026.
  • Employees Provident Fund Board sold 1,359,663 Merck shares in Q2 2026, an estimated $159M.
  • Merck made up 0.39% of Employees Provident Fund Board's portfolio in Q2 2026, its #42 holding.
  • Employees Provident Fund Board first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Employees Provident Fund Board's Merck position peaked at $254M in Q4 2025.
  • 3,813 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Employees Provident Fund Board's 13F filing for Q2 2026, filed 12 Aug 2026.